134 related articles for article (PubMed ID: 5967371)
1. The inhibition of neuraminidase and antiviral action.
Edmond JD; Johnston RG; Kidd D; Rylance HJ; Sommerville RG
Br J Pharmacol Chemother; 1966 Aug; 27(2):415-26. PubMed ID: 5967371
[No Abstract] [Full Text] [Related]
2. Inability of isoquinoline derivatives to inhibit virus neuraminidase activity.
Shinkai K; Nishimura T
J Gen Virol; 1972 Aug; 16(2):227-9. PubMed ID: 5072367
[No Abstract] [Full Text] [Related]
3. [Favipiravir, a new concept of antiviral drug against influenza viruses].
Reina J; Reina N
Rev Esp Quimioter; 2017 Apr; 30(2):79-83. PubMed ID: 28176519
[TBL] [Abstract][Full Text] [Related]
4. [Virus inhibition in vitro by semioxamazide derivatives].
Heinisch L; Küchler C; Küchler W
Arzneimittelforschung; 1968 Oct; 18(10):1324-8. PubMed ID: 4974422
[No Abstract] [Full Text] [Related]
5. Kelp extracts as antiviral substances.
Kathan RH
Ann N Y Acad Sci; 1965 Jul; 130(1):390-7. PubMed ID: 5216630
[No Abstract] [Full Text] [Related]
6. Antiviral susceptibility of influenza viruses isolated from patients pre- and post-administration of favipiravir.
Takashita E; Ejima M; Ogawa R; Fujisaki S; Neumann G; Furuta Y; Kawaoka Y; Tashiro M; Odagiri T
Antiviral Res; 2016 Aug; 132():170-7. PubMed ID: 27321665
[TBL] [Abstract][Full Text] [Related]
7. [Genetic markers and their interrelationships in influenza viruses. 3. The interrelationship between virulence and sensitivity to serum inhibitors, neuraminidase and eluting activity].
Sokolov MI; Shvachkina VI; Molibog EV
Vopr Virusol; 1970; 15(4):488-92. PubMed ID: 5505413
[No Abstract] [Full Text] [Related]
8. [Neuraminidase inhibitors resistance in influenza viruses and the related mechanisms].
Huang L; Zhou JF; Wei H; Shu YL
Bing Du Xue Bao; 2012 Sep; 28(5):572-6. PubMed ID: 23233936
[TBL] [Abstract][Full Text] [Related]
9. [Sensitivity of influenza A2 virus to the non-specific alpha-inhibitor of Francis (the thermoresistance of the sialidase of several variants of influenza A2 virus)].
Fridman EA; Vishnevskiĭ VG; Sinitskiĭ AA
Vopr Virusol; 1969; 14(6):691-5. PubMed ID: 5369469
[No Abstract] [Full Text] [Related]
10. [In vitro characteristics of largely genetically homogenous influenza virus A2 strains].
Gerth HJ
Arch Gesamte Virusforsch; 1970; 30(4):275-90. PubMed ID: 4318622
[No Abstract] [Full Text] [Related]
11. Serum inhibitors of A 2 -Hong Kong influenza virus haemagglutination.
Shortridge KF; Lansdell A
Microbios; 1972 Dec; 6(24):213-9. PubMed ID: 4348986
[No Abstract] [Full Text] [Related]
12. The antiviral activity of caprochlorone.
Stanfield FJ; Haff RF; Stewart RC
Proc Soc Exp Biol Med; 1967 May; 125(1):297-303. PubMed ID: 6027546
[No Abstract] [Full Text] [Related]
13. A QSAR study on influenza neuraminidase inhibitors.
Verma RP; Hansch C
Bioorg Med Chem; 2006 Feb; 14(4):982-96. PubMed ID: 16213733
[TBL] [Abstract][Full Text] [Related]
14. Method for determining antineuraminidase activity.
Wagner RB; Steinberg BA; Ruchman I
Appl Microbiol; 1967 Mar; 15(2):239-42. PubMed ID: 6029825
[TBL] [Abstract][Full Text] [Related]
15. Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.
Sun J; Mei H
Chem Biol Drug Des; 2012 May; 79(5):863-8. PubMed ID: 22251826
[TBL] [Abstract][Full Text] [Related]
16. [Screening bioactive compounds inhibiting influenza virus from isatidis radix by ultrafiltration mass spectrometry].
Ma LN; Zhang CE; Yan D; Tan MR; Li HB; Zhang LL; Xiong Y; Xiao XH
Zhongguo Zhong Yao Za Zhi; 2014 Mar; 39(5):812-6. PubMed ID: 25204170
[TBL] [Abstract][Full Text] [Related]
17. Discovery of berberine based derivatives as anti-influenza agent through blocking of neuraminidase.
Enkhtaivan G; Muthuraman P; Kim DH; Mistry B
Bioorg Med Chem; 2017 Oct; 25(20):5185-5193. PubMed ID: 28958846
[TBL] [Abstract][Full Text] [Related]
18. [Use of synthetic inhibitors of neuraminidase and hemagglutinin for studying the functional role of active subunits of membranes of myxo- and paramyxoviruses].
Zakstel'skaia LIa; Molibog EV; Iakhno MA; Evstigneeva NA; Isachenko VA
Vopr Virusol; 1972; 17(2):223-8. PubMed ID: 4337525
[No Abstract] [Full Text] [Related]
19. Discovery of (E)-1-amino-4-phenylbut-3-en-2-ol derivatives as novel neuraminidase inhibitors.
Lu C; Yin Y; Meng F; Dun Y; Pei K; Wang C; Xu X; Wu F
Bioorg Med Chem Lett; 2018 Jun; 28(11):2003-2007. PubMed ID: 29748050
[TBL] [Abstract][Full Text] [Related]
20. Berberine-piperazine conjugates as potent influenza neuraminidase blocker.
Enkhtaivan G; Kim DH; Park GS; Pandurangan M; Nicholas DA; Moon SH; Kadam AA; Patel RV; Shin HS; Mistry BM
Int J Biol Macromol; 2018 Nov; 119():1204-1210. PubMed ID: 30099043
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
